busulfan has been researched along with Inborn Errors of Metabolism in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In high-risk malignancy, low acute toxicity was followed by low TRM but it did not translate into increased survival." | 2.78 | Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience. ( Bader, P; Beier, R; Ehlert, K; Eyrich, M; Greil, J; Gruhn, B; Holter, W; Hönig, M; Meisel, R; Müller, I; Nürnberger, W; Sauer, M; Schlegel, PG; Schulz, A; Stachel, KD; Suttorp, M; Sykora, KW; Urban, C; Wössmann, W; Zimmermann, M, 2013) |
| "Busulfan was quantitated using ultraviolet absorbance detection after derivatization and HPLC separation." | 1.32 | Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation. ( Blazar, B; Bostrom, B; Bruns, A; Enockson, K; Johnson, A, 2003) |
| " Thus, we have developed a safe chemotherapy schedule for transplantation that avoids the need for radiotherapy and can, if necessary, be repeated after a 3-month interval." | 1.27 | Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. ( Barnes, R; Downie, CJ; Hobbs, JR; Hugh-Jones, K; Shaw, PJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beier, R | 1 |
| Schulz, A | 1 |
| Hönig, M | 1 |
| Eyrich, M | 1 |
| Schlegel, PG | 1 |
| Holter, W | 1 |
| Stachel, KD | 1 |
| Ehlert, K | 1 |
| Greil, J | 1 |
| Nürnberger, W | 1 |
| Wössmann, W | 1 |
| Bader, P | 1 |
| Urban, C | 1 |
| Müller, I | 1 |
| Suttorp, M | 1 |
| Sauer, M | 1 |
| Gruhn, B | 1 |
| Meisel, R | 1 |
| Zimmermann, M | 1 |
| Sykora, KW | 1 |
| Bostrom, B | 1 |
| Enockson, K | 1 |
| Johnson, A | 1 |
| Bruns, A | 1 |
| Blazar, B | 1 |
| Bakker, B | 1 |
| Oostdijk, W | 1 |
| Bresters, D | 1 |
| Walenkamp, MJ | 1 |
| Vossen, JM | 1 |
| Wit, JM | 1 |
| Classen, CF | 1 |
| Schulz, AS | 1 |
| Sigl-Kraetzig, M | 1 |
| Hoffmann, GF | 1 |
| Simmonds, HA | 1 |
| Fairbanks, L | 1 |
| Debatin, KM | 1 |
| Friedrich, W | 1 |
| Shaw, PJ | 1 |
| Hugh-Jones, K | 1 |
| Hobbs, JR | 1 |
| Downie, CJ | 1 |
| Barnes, R | 1 |
1 trial available for busulfan and Inborn Errors of Metabolism
| Article | Year |
|---|---|
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Austria; Bone Marrow Transplantation; Busulfan | 2013 |
4 other studies available for busulfan and Inborn Errors of Metabolism
| Article | Year |
|---|---|
Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation.
Topics: Adolescent; Adult; Area Under Curve; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; | 2003 |
Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Body Height; Busulfan; Calcium; Child; Child, Prescho | 2004 |
Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Family Health | 2001 |
Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.
Topics: Adolescent; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosph | 1986 |